RPL7P34

Across TCGA pan-cancer cohorts, RPL7P34 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RPL7P34 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher RPL7P34 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RPL7P34 expression acts as an unfavorable survival marker, although some lineages such as LGG show a favorable association.

MESO, LIHC, and CHOL are the cancer types where RPL7P34 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Tertile	II,III,IV	0.330	0.581	.035	45	view →
LIHC	OS	Tertile	III,IV	0.187	0.660	<.001	45	view →
CHOL	DFS	Tertile	All	0.118	0.514	.020	36	view →
KICH	DFS	Tertile	All	0.521	0.969	.037	27	view →
KIRC	DFS	Tertile	All	0.375	0.659	.004	24	view →
SARC	OS	Tertile	All	0.509	0.758	.002	21	view →
READ	DFS	Tertile	IV	0.027	0.636	<.001	18	view →
DLBC	OS	Tertile	II,III,IV	0.118	0.802	.025	18	view →
THCA	OS	Tertile	IV	0.095	0.966	<.001	18	view →
KIRP	DFS	Tertile	II,III,IV	0.122	0.626	.032	18	view →
UCEC	OS	Tertile	All	0.805	0.881	.024	12	view →
LGG	DFS	Tertile	All	1.000	0.712	.023	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

RPL7P34–MESO (OS)

Open the MESO breakdown →